Cellectis Adr (CLLS)

Oct 21, 2025

European ADRs Dip As Biotech Stocks Tumble In US Trading - Finimize

Oct 21, 2025

Oct 18, 2025

Barclays Remains a Buy on Cellectis SA (CLLS) - The Globe and Mail

Oct 18, 2025

Oct 18, 2025

Barclays raises Cellectis stock price target to $8 on promising cancer therapy - Investing.com Philippines

Oct 18, 2025

Oct 17, 2025

Jefferies raises Cellectis stock price target to $6 after R&D day - Investing.com

Oct 17, 2025

Oct 16, 2025

Enerpac Tool Group Posts Upbeat Results, Joins Praxis Precision Medicines, J B Hunt, Salesforce And Other Big Stocks Moving Higher On Thursday - Benzinga

Oct 16, 2025

Oct 14, 2025

Operating cash flow per share of Cellectis S.A. Sponsored ADR – LSX:A14QZE - TradingView

Oct 14, 2025

Oct 13, 2025

Pre Market Movers: NBTX, IMTX, QNRX See Big Swings - RTTNews

Oct 13, 2025

Oct 08, 2025

Cellectis’s SWOT analysis: gene therapy firm’s stock poised for growth? - Investing.com

Oct 08, 2025

Oct 01, 2025

European Pharma And Biotech Companies Led ADR Gains In The US - Finimize

Oct 01, 2025

Sep 29, 2025

Inventiva, MoonLake Immunotherapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga

Sep 29, 2025

Sep 20, 2025

European Stocks In The US Close The Week Mostly Steady - Finimize

Sep 20, 2025

Sep 11, 2025

Biotech And Tech Firms Drive Gains For European ADRs - Finimize

Sep 11, 2025

Sep 11, 2025

European ADRs Dip Slightly As Biotech Stocks Jump And Drop - Finimize

Sep 11, 2025

Aug 30, 2025

Cellectis Reports Second Quarter 2025 Financial Results & Business Updates - ADVFN Brasil

Aug 30, 2025

Aug 21, 2025

European ADRs Under Pressure: Sector Divergence and Strategic Entry Points - AInvest

Aug 21, 2025

Aug 13, 2025

Cellectis’s SWOT analysis: gene therapy firm’s stock faces pivotal moment - Investing.com

Aug 13, 2025

Aug 05, 2025

Earnings call transcript: Cellectis Q2 2025 earnings miss drives stock down 13% - Investing.com

Aug 05, 2025

Aug 04, 2025

Cellectis earnings missed by $0.02, revenue topped estimates - Investing.com India

Aug 04, 2025

Aug 04, 2025

Cellectis earnings missed by $0.02, revenue topped estimates By Investing.com - Investing.com South Africa

Aug 04, 2025

Aug 01, 2025

European Stocks Dip As US Holders Turn Cautious - Finimize

Aug 01, 2025

Jul 28, 2025

Unlocking Oncology’s Future: 3 Trending Cancer Biotech Stocks With ‘Strong Buy’ Ratings - Barchart.com

Jul 28, 2025

Jul 24, 2025

European ADRs Inch Higher As Drugmakers Shine - Finimize

Jul 24, 2025

Jul 21, 2025

Cellectis shares surge 66% following InvestingPro’s April Fair Value alert By Investing.com - Investing.com India

Jul 21, 2025

Jul 16, 2025

European Stocks Falter On Wall Street As ADR Index Drops - Finimize

Jul 16, 2025

Jul 03, 2025

European Equities Slip While Biopharma Stocks Shine - Finimize

Jul 03, 2025

Jun 16, 2025

European Stocks Shine As ADRs Climb Higher - Finimize

Jun 16, 2025

Jun 13, 2025

European ADRs Dip With Some Stocks Rising Above The Crowd - Finimize

Jun 13, 2025

May 26, 2025

Cellectis’s SWOT analysis: gene therapy firm’s stock faces pivotal year By Investing.com - Investing.com South Africa

May 26, 2025

May 26, 2025

Cellectis’s SWOT analysis: gene therapy firm’s stock faces pivotal year - Investing.com

May 26, 2025